Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT03116529 |
| Title | Neoadjuvant Durvalumab and Tremelimumab Plus Radiation for High Risk Soft-Tissue Sarcoma (NEXIS) |
| Acronym | NEXIS |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | University of Maryland, Baltimore |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Arizona | Tucson | Arizona | 85724 | United States | Details | |
| University of Maryland Medical Center, Greenebaum Comprehensive Cancer Center | Baltimore | Maryland | 21201 | United States | Details | |
| Allegheny General Hospital | Pittsburgh | Pennsylvania | 15212 | United States | Details |